CHPG (sodium salt)


CAS No. : 1303993-73-8

1303993-73-8
Price and Availability of CAS No. : 1303993-73-8
Size Price Stock
5mg $50 In-stock
10mg $80 In-stock
25mg $175 In-stock
50mg $315 In-stock
100mg $560 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-101364A
M.Wt: 223.59
Formula: C8H7ClNNaO3
Purity: >98 %
Solubility: H2O : 6.67 mg/mL (ultrasonic;warming;heat to 80°C);DMSO : 100 mg/mL (ultrasonic)
Introduction of 1303993-73-8 :

CHPG sodium salt is a selective mGluR5 agonist, and attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-κB pathway in BV2 microglial cells[1]. CHPG sodium salt protects against traumatic brain injury (TBI) in vitro and in vivo by activation of the ERK and Akt signaling pathways.[2]. IC50 & Target: mGluR5, TSG-6/NF-κB[1], ERK, Akt[2] In Vitro: CHPG sodium salt (10-500 µM; 24 hours) significantly increases the cell viability and decreases the LDH release after SO2 derivatives treatment[1].
CHPG sodium salt (0.5 mM; 30 mins ) protects BV2 cells against SO2-induced apoptosis[1].
CHPG sodium salt (0.5 mM; 30 mins) treatment alone increases the expression of TSG-6 in both mRNA and protein levels[1].
In Vivo: CHPG sodium salt (injection; 250 nM; for 7 days) reduces significantly cerebral lesion volume[2].

Your information is safe with us.